Originally introduced as a bone void filler for large orthopedic reconstructive procedures, the new smaller size can be used where smaller amounts of demineralized bone matrix are required.
Read Integra LifeSciences’ release on its Accell Evo3 Demineralized Bone Matrix.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
